New Advance in Percutaneous Coronary Interventions
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".
Deadline for manuscript submissions: 20 November 2024 | Viewed by 57
Special Issue Editors
Interests: interventional cardiology; intravascular ultrasound (IVUS); coronary imaging; optical coherence tomography (OCT); percutaneous coronary intervention (PCI); bioresorbable scaffold (BRS); drug-coated balloon (DCB)
Interests: interventional cardiology; intravascular ultrasound (IVUS); coronary imaging; optical coherence tomography (OCT); percutaneous coronary intervention (PCI); bioresorbable scaffold (BRS); drug-coated balloon (DCB)
Special Issue Information
Dear Colleagues,
In recent decades, interventional cardiology has been moving into the “leave nothing behind” stage of treating coronary artery disease. In fact, although eternal prostheses, i.e., metal stents and new-generation drug-eluting stents (DES), remain the best option for the treatment of coronary artery disease, they are affected by stent thrombosis due to the presence of metal in the coronary arteries and, avoiding this complication, by the need for dual antiplatelet therapy (DAPT). From this persepctive, drug-coated balloons (DCBs), both paclitaxel and sirolimus, are effective and safe. Their advantage is their absence of a metal prosthesis, which allows a shorter DAPT and is free from thrombosis related to the use of a durable metal stent. An interesting technology is also the biovascular resorbable scaffold (BRS), which is characterized by a scaffolding effect. Another is the metal stent, which progressively decreases over time, restoring vasomotility and healing the vessels from the atherosclerotic lesion. Their application is also useful in specific settings affected by spontaneous coronary dissection (SCAD), in which our group has gained experience for several years. Here, we present a literature review on the matter and also share our own experience.
Dr. Giovanna Geraci
Dr. Dario Buccheri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- interventional cardiology
- intravascular ultrasound (IVUS)
- coronary imaging
- optical coherence tomography (OCT)
- percutaneous coronary intervention (PCI)
- bioresorbable scaffold (BRS)
- drug-coated balloon (DCB)
